Corrigendum to Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice [Neuroscience, 223, (2012), 102-113] DOI: 10.1016/j.neuroscience.2012.06.054;Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice

Neuroscience

Volumn 223, Issue , 2012, Pages 102-113

  Halloran, J ^a,b   Hussong, S A ^a,b   Burbank, R ^a,b   Podlutskaya, N ^a,b   Fischer, K E ^a,b   Sloane, L B ^a   Austad, S N ^a,b   Strong, R ^a,b,d   Richardson, A ^a,b,d   Hart, M J ^a,c   Galvan, V ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c Department of Cell and Structural Biology ^*  (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Anxiety; Brain aging; Depression; Mammalian target of rapamycin; Memory; Monoamines

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; NORADRENALIN; RAPAMYCIN; SEROTONIN;

ADRENALIN BRAIN LEVEL; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DEPRESSION; DOPAMINE BRAIN LEVEL; FEMALE; LEARNING; MALE; MEMORY; MESENCEPHALON; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; TRANQUILIZING ACTIVITY;

EID: 84865525400     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.08.028     Document Type: Erratum

References (55)

1. Adams M.M., Shi L., Linville M.C., Forbes M.E., Long A.B., Bennett C., Newton I.G., Carter C.S., Sonntag W.E., Riddle D.R., Brunso-Bechtold J.K. Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability. Exp Neurol 2008, 211:141-149.
2. Adell A., Celada P., Abellan M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Brain Res Rev 2002, 39:154-180.
3. Blagosklonny M.V. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 2010, 9:3151.
4. Burger J.M., Buechel S.D., Kawecki T.J. Dietary restriction affects lifespan but not cognitive aging in Drosophila melanogaster. Aging Cell 2010, 9:327-335.
5. Caccamo A., Majumder S., Richardson A., Strong R., Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem 2010, 285:13107-13120.
6. Cho S.H., Sun B., Zhou Y., Kauppinen T.M., Halabisky B., Wes P., Ransohoff R.M., Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem 2011, 286:32713-32722.
7. Cloughesy T.F., Yoshimoto K., Nghiemphu P., Brown K., Dang J., Zhu S., Hsueh T., Chen Y., Wang W., Youngkin D., Liau L., Martin N., Becker D., Bergsneider M., Lai A., Green R., Oglesby T., Koleto M., Trent J., Horvath S., Mischel P.S., Mellinghoff I.K., Sawyers C.L. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 2008, 5:e8.
8. Crawley J.N. What's wrong with my mouse? 2000, Wyley-Liss, New York.
9. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
10. Da Cunha C., Wietzikoski S., Wietzikoski E.C., Miyoshi E., Ferro M.M., Anselmo-Franci J.A., Canteras N.S. Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system. Neurobiol Learn Mem 2003, 79:236-242.
11. Dal-Pan A., Pifferi F., Marchal J., Picq J.L., Aujard F. Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate. PLoS One 2011, 6:e16581.
12. Dogan S., Johannsen A.C., Grande J.P., Cleary M.P. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors. Nutr Cancer 2011, 63:389-401.
13. Elliott R., Zahn R., Deakin J.F., Anderson I.M. Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 2011, 36:153-182.
14. Finch C.E., Austad S.N. Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging. Age 2012, Epub ahead of print.
15. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., Carlson E., Sagi S.A., Chevallier N., Jin K., Greenberg D.A., Bredesen D.E. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 2006, 103:7130-7135.
16. Galvan V., Zhang J., Gorostiza O.F., Banwait S., Huang W., Ataie M., Tang H., Bredesen D.E. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav Brain Res 2008, 191:246-255.
17. Gresack J.E., Frick K.M. Male mice exhibit better spatial working and reference memory than females in a water-escape radial arm maze task. Brain Res 2003, 982:98-107.
18. Hariri A.R., Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006, 10:182-191.
19. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., Pahor M., Javors M.A., Fernandez E., Miller R.A. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
20. Hawley W.R., Grissom E.M., Barratt H.E., Conrad T.S., Dohanich G.P. The effects of biological sex and gonadal hormones on learning strategy in adult rats. Physiol Behav 2012, 105:1014-1020.
21. Heimovics S.A., Salvante K.G., Sockman K.W., Riters L.V. Individual differences in the motivation to communicate relate to levels of midbrain and striatal catecholamine markers in male European starlings. Horm Behav 2011, 60:529-539.
22. Hoeffer C.A., Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 2009, 33:67-75.
23. Huber K.M., Roder J.C., Bear M.F. Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1. J Neurophysiol 2001, 86:321-325.
24. Kapahi P., Chen D., Rogers A.N., Katewa S.D., Li P.W., Thomas E.L., Kockel L. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab 2010, 11:453-465.
25. Kapahi P., Zid B. TOR pathway: linking nutrient sensing to life span. Sci Aging Knowledge Environ 2004, 2004(36):PE34.
26. Komatsu T., Chiba T., Yamaza H., Yamashita K., Shimada A., Hoshiyama Y., Henmi T., Ohtani H., Higami Y., de Cabo R., Ingram D.K., Shimokawa I. Manipulation of caloric content but not diet composition, attenuates the deficit in learning and memory of senescence-accelerated mouse strain P8. Exp Gerontol 2008, 43:339-346.
27. Lang U.E., Heger J., Willbring M., Domula M., Matschke K., Tugtekin S.M. Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement. Transplant Proc 2009, 41:4285-4288.
28. Mains R.E., Patterson P.H. Primary cultures of dissociated sympathetic neurons. II. Initial studies on catecholamine metabolism. J Cell Biol 1973, 59:346-360.
29. Margolis E.B., Lock H., Hjelmstad G.O., Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J Physiol 2006, 577:907-924.
30. Martin B., Pearson M., Kebejian L., Golden E., Keselman A., Bender M., Carlson O., Egan J., Ladenheim B., Cadet J.L., Becker K.G., Wood W., Duffy K., Vinayakumar P., Maudsley S., Mattson M.P. Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology 2007, 148:4318-4333.
31. Martin D.E., Hall M.N. The expanding TOR signaling network. Curr Opin Cell Biol 2005, 17:158-166.
32. Martinez-Sanchis S., Bernal M.C., Montagud J.V., Candela G., Crespo J., Sancho A., Pallardo L.M. Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: a pilot study. J Clin Exp Neuropsychol 2011, 33:1016-1024.
33. Mattson M.P., Duan W., Chan S.L., Cheng A., Haughey N., Gary D.S., Guo Z., Lee J., Furukawa K. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol Aging 2002, 23:695-705.
34. Michalek R.D., Rathmell J.C. Methed-up FOXOs can't in-Akt-ivate. Mol Cell 2008, 32:160-162.
35. Monti J.M. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep. Sleep Med Rev 2010, 14:319-327.
36. Morgane P.J., Galler J.R., Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 2005, 75:143-160.
37. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
38. Papakostas G.I., Trivedi M.H., Alpert J.E., Seifert C.A., Krishen A., Goodale E.P., Tucker V.L. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: a meta-analysis of individual patient data from 10 double-blind, randomized clinical trials. J Psychiatr Res 2008, 42:134-140.
39. Pechnick R.N., Chesnokova V.M., Kariagina A., Price S., Bresee C.J., Poland R.E. Reduced immobility in the forced swim test in mice with a targeted deletion of the leukemia inhibitory factor (LIF) gene. Neuropsychopharmacology 2004, 29:770-776.
40. Polak P., Hall M.N. mTOR and the control of whole body metabolism. Curr Opin Cell Biol 2009, 21:209-218.
41. Rodgers R.J. Animal models of 'anxiety': where next?. Behav Pharmacol 1997, 8:477-496.
42. Salih D.A., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008, 20:126-136.
43. Sarbassov D.D., Ali S.M., Sabatini D.M. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005, 17:596-603.
44. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 2006, 22:159-168.
45. Sharp T., Cowen P.J. 5-HT and depression: is the glass half-full?. Curr Opin Pharmacol 2011, 11:45-51.
46. Simon N.M., Kaufman R.E., Hoge E.A., Worthington J.J., Herlands N.N., Owens M.E., Pollack M.H. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther 2009, 15:19-23.
47. Siuta M.A., Robertson S.D., Kocalis H., Saunders C., Gresch P.J., Khatri V., Shiota C., Kennedy J.P., Lindsley C.W., Daws L.C., Polley D.B., Veenstra-Vanderweele J., Stanwood G.D., Magnuson M.A., Niswender K.D., Galli A. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 2010, 8:e1000393.
48. Spilman P., Podlutskaya N., Hart M.J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 2010, 5:e9979.
49. Stamford J.A., Davidson C., McLaughlin D.P., Hopwood S.E. Control of dorsal raphe 5-HT function by multiple 5-HT(1) autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci 2000, 23:459-465.
50. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci U S A 2002, 99:467-472.
51. Tecott L.H., Nestler E.J. Neurobehavioral assessment in the information age. Nat Neurosci 2004, 7:462-466.
52. Tollefson G.D., Lancaster S.P., Montague-Clouse J. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. Psychopharmacol Bull 1991, 27:163-170.
53. Watt M.J., Burke A.R., Renner K.J., Forster G.L. Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. Behav Neurosci 2009, 123:564-576.
54. Witte A.V., Fobker M., Gellner R., Knecht S., Floel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A 2009, 106:1255-1260.
55. Zhang J., Gorostiza O.F., Tang H., Bredesen D.E., Galvan V. Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience. Behav Brain Res 2009, 1:1-2.